ValueQ4, 24Q1, 25Q2, 25Q3, 25TTMCash from investing activities66.13 M-44.38 M-1.56 M51.29 M71.47 MCash from financing activities-98 K14 K1 0000-83 KFree cash flow-27.54 M-12.31 M-21.83 M-10.89 M-72.58 M
Silence Therapeutics Plc - American Depository Share
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.